NCL-ETP

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNCL-ETP
Drug Alias NameNCL-ETP
ClassificationSmall molecules > Lipid
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCARLINA Technologies SAS
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCARLINA Technologies SAS
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A